Related Experiment Videos
Vascular remodeling in varicose veins
M M Kockx1, M W Knaapen, H E Bortier
1Department of Pathology, AZ Middelheim, Antwerpen, Belgium. mark.kockx@uia.ua.ac.be
Angiology
|November 20, 1998
Summary
Varicose veins show hypertrophic smooth muscle cells (SMC) and disorganized elastin, leading to venous wall weakness. These cellular changes in SMC and elastin disruption are key to understanding varicose vein disease progression.
Area of Science:
- Vascular Biology
- Histopathology
- Cellular Biology
Background:
- Varicose veins are a common vascular disease.
- The structural integrity of the venous wall is crucial for proper function.
- Changes in the circular layer of the venous wall, particularly in smooth muscle cells (SMC) and elastin, are implicated in venous disease.
Purpose of the Study:
- To histopathologically compare varicose and normal saphenous veins.
- To investigate changes in the circular layer of the venous wall, focusing on smooth muscle cells (SMC) and elastin.
- To correlate cellular changes with the structural integrity of the venous wall.
Main Methods:
- Histologic examination of varicose (n=29) and normal (n=17) saphenous veins using light and transmission electron microscopy.
- Semiquantitative grading of SMC hypertrophy and elastin pattern.
- Measurement of SMC and collagen volume densities, SMC diameter, and SMC nuclei count per area.
Main Results:
- Varicose veins exhibit hypertrophic SMC and disorganized elastin patterns compared to normal veins.
- A significant correlation was found between hypertrophic SMC and abnormal elastin patterns (r=0.658, p<0.001).
- SMC diameter and nuclei count per area were significantly different in varicose veins versus normal veins (p<0.001).
Conclusions:
- Cellular hypertrophy of SMC and observed microherniations may cause elastin fiber disruption in varicose veins.
- Disrupted connections between SMC and elastin fibers likely contribute to venous wall weakness in varicose vein disease.
- Understanding these cellular mechanisms is vital for addressing varicose vein pathology.